Novelna News
Our most recent Events, Press Releases and Novelna in the media
Press Releases
-
Novelna Welcomes Mark Morgan to Advisory Board, Expanding Expertise in U.S. Market Access and Healthcare Innovation
[...] With over 30 years of experience in healthcare and biotechnology, Morgan brings deep expertise in U.S. market access, healthcare system partnerships, and operational leadership. [...]
-
Novelna Welcomes Nader Gamini as Chief Operating Officer
Novelna, a biotech company specializing in early cancer detection, is pleased to announce the appointment of Nader Gamini as its new Chief Operating Officer (COO). With nearly four decades of experience across the semiconductor and biotech industries, Nader’s expertise will play a critical role in accelerating [...]
-
Novelna Expands Advisory Board with Strategic and Business Development Leaders
May 31, 2024
Novelna, a proteomics-based liquid biopsy startup, is pleased to welcome two distinguished advisors to its advisory board. This strategic move aims to accelerate Novelna's product development efforts and enhance its potential market position. […]
-
Novelna Inc. Announces Groundbreaking Cancer Screening Test – A Major Step Toward Early Detection and Personalized Healthcare
January 9, 2024
Novelna Inc., a proteomics-based liquid biopsy startup, today announced a pioneering development in cancer screening, as detailed in a recent study published in BMJ Oncology. This novel test, utilizing a sex-specific panel of 10 proteins, can detect 18 different early-stage cancers, representing a monumental step forward in the fight against one of the world's most prevalent diseases. […]
Events
-
Advancing Diagnostic Accessibility: Insights from Industry Leaders
June 19, 2024
The recent webinar, "NextGen Diagnostics: Democratizing Access to Advanced Screening," brought together a panel of experts to discuss the integration of cutting-edge technologies into diagnostic practices, with a strong focus on making these tools accessible to underserved populations. […]
In the Media
-
October 2, 2024
DeciBio - Exploring Proteomics: New Approaches to Early Cancer Detection
-
September 17, 2024
CEO Weekly - Novelna Shows Potential for Early Cancer Detection
-
June 28, 2024
International Business Times - Dr. Ashkan Afshin Is Steadily Unlocking The Potential Of Biotechnology To Revolutionize Healthcare
-
June 12, 2024
LA Weekly - Novelna is Breaking New Ground with its Early Cancer Detection Solutions
-
June 6, 2024
World Economic Forum - 11 new breakthroughs in the fight against cancer
-
June 5, 2024
Drug Discovery News— A sex-specific protein panel detects early-stage cancers
-
February 23, 2024
Endpoint News — Once a scientific backwater, protein research attracts billion-dollar deals and high-profile publications
-
January 12, 2024
genomeweb —Novelna Developing Low-Cost Proteomic Multi-Cancer Test Following Positive Proof of Concept
-
January 10, 2024
Independent — New DNA test can detect 18 different types of early stage cancers, scientists say
-
January 10, 2024
Drugs.com — Sex-Specific Detection Panels Show High Accuracy for Early-Stage Cancer
-
January 10, 2024
The Telegraph — New generation of ‘highly accurate’ cancer tests could be used to screen all major organs
-
January 9, 2024
The Guardian — Protein test can detect 18 early stage cancers, scientists say